Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN)

Publikation: Bidrag til tidsskriftReviewForskningpeer review


  1. An ontological foundation for ocular phenotypes and rare eye diseases

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Research activity and capability in the European reference network MetabERN

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Longitudinal Increases in Serum Insulin-like Factor 3 and Testosterone Determined by LC-MS/MS in Pubertal Danish Boys

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Marked increase in incident gynecomastia: a 20-year national registry study, 1998 to 2017

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Marked Increase in Incident Gynecomastia: A 20-Year National Registry Study, 1998 to 2017

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Thomas Eggermann
  • Miriam Elbracht
  • Ingo Kurth
  • Anders Juul
  • Trine Holm Johannsen
  • Irène Netchine
  • George Mastorakos
  • Gudmundur Johannsson
  • Thomas J Musholt
  • Martin Zenker
  • Dirk Prawitt
  • Alberto M Pereira
  • Olaf Hiort
  • European Reference Network on Rare Endocrine Conditions (ENDO-ERN
Vis graf over relationer

BACKGROUND: With the development of molecular high-throughput assays (i.e. next generation sequencing), the knowledge on the contribution of genetic and epigenetic alterations to the etiology of inherited endocrine disorders has massively expanded. However, the rapid implementation of these new molecular tools in the diagnostic settings makes the interpretation of diagnostic data increasingly complex.

MAIN BODY: This joint paper of the ENDO-ERN members aims to overview chances, challenges, limitations and relevance of comprehensive genetic diagnostic testing in rare endocrine conditions in order to achieve an early molecular diagnosis. This early diagnosis of a genetically based endocrine disorder contributes to a precise management and helps the patients and their families in their self-determined planning of life. Furthermore, the identification of a causative (epi)genetic alteration allows an accurate prognosis of recurrence risks for family planning as the basis of genetic counselling. Asymptomatic carriers of pathogenic variants can be identified, and prenatal testing might be offered, where appropriate.

CONCLUSIONS: The decision on genetic testing in the diagnostic workup of endocrine disorders should be based on their appropriateness to reliably detect the disease-causing and -modifying mutation, their informational value, and cost-effectiveness. The future assessment of data from different omic approaches should be embedded in interdisciplinary discussions using all available clinical and molecular data.

TidsskriftOrphanet Journal of Rare Diseases
Udgave nummer1
Sider (fra-til)144
StatusUdgivet - 8 jun. 2020

ID: 60160497